← Open Payments lookup

MARCUS DANIELS: Open Payments

NPI 1962072363 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,106 in 112 payments from 18 companies in 2025. Trend: 2023 $2,371 · 2024 $1,310 · 2025 $2,106

Food & beverage: $2,106
CompanyPaymentsAmount
ABBVIE INC.30$454
Corium, LLC16$252
Supernus Pharmaceuticals, Inc.12$233
Alkermes, Inc.7$217
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$161
Takeda Pharmaceuticals U.S.A., Inc.7$134
Lundbeck LLC4$94
Axsome Therapeutics, Inc.4$80
Vanda Pharmaceuticals Inc.3$77
Otsuka America Pharmaceutical, Inc.3$73

Products named: VRAYLAR, Azstarys, Qelbree, LYBALVI, CAPLYTA, REXULTI, TRINTELLIX, Auvelity.

Industry payments across AZ — which companies pay providers there.